ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Cerebral-circulatory Response to Intravenous Antihypertensive Treatment in Women With Serious Preeclampsia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00403572
Recruitment Status : Completed
First Posted : November 23, 2006
Last Update Posted : October 17, 2016
Sponsor:
Information provided by (Responsible Party):
Eldrid Langesæter, Oslo University Hospital

Brief Summary:
The purpose of this study is a systematical registration of hemodynamic measurements (cardiac output, blood pressure and systemic vascular resistance) in women with serious preeclampsia.

Condition or disease
Preeclampsia

Study Type : Observational
Actual Enrollment : 8 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: A Study of Cerebral-circulatory Response to Intravenous Antihypertensive Treatment in Women With Serious Preeclampsia
Study Start Date : November 2006
Actual Primary Completion Date : January 2009
Actual Study Completion Date : January 2009

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. Hemodynamic and cerebral-circulatory variations in preeclamptic women [ Time Frame: days ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 50 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Pregnant women with moderate-to-severe pre-eclapmsia
Criteria

Inclusion Criteria:

  • Women with serious preeclampsia

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00403572


Sponsors and Collaborators
Oslo University Hospital
Investigators
Principal Investigator: Eldrid Langesæter, PhD, MD Oslo University Hospital

Responsible Party: Eldrid Langesæter, MD PhD, Oslo University Hospital
ClinicalTrials.gov Identifier: NCT00403572     History of Changes
Other Study ID Numbers: ElangeTCD-2006
S-06348b
First Posted: November 23, 2006    Key Record Dates
Last Update Posted: October 17, 2016
Last Verified: October 2016

Keywords provided by Eldrid Langesæter, Oslo University Hospital:
Preeclampsia
Trans cranial Doppler
Cardiac output
systemic vascular resistance
blood pressure

Additional relevant MeSH terms:
Pre-Eclampsia
Hypertension, Pregnancy-Induced
Pregnancy Complications
Antihypertensive Agents